|
May 2
|
Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
|
|
Apr 30
|
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
|
|
Apr 18
|
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
|
|
Apr 5
|
Despite shrinking by US$135m in the past week, Twist Bioscience (NASDAQ:TWST) shareholders are still up 132% over 1 year
|
|
Mar 28
|
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
|
|
Mar 5
|
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
|
|
Feb 10
|
Twist Bioscience Corp Director Robert Chess Sells 4,110 Shares
|
|
Jan 16
|
Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024
|
|
Jan 8
|
Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
|
|
Jan 5
|
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
|
|
Dec 18
|
Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 1
|
5 Best Performing Stocks of the Top ETF of November
|
|
Aug 22
|
Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene
|
|
Apr 28
|
Twist Bioscience (TWST) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Apr 27
|
Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
|
|
Apr 26
|
12 Gene Editing Stocks With the Best Long-Term Potential
|
|
Apr 25
|
Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought
|
|
Apr 25
|
The 7 Best Biotech Stocks for Personalized Medicine Investors
|